Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jan 22, 10:35

US Stock Market Today: S&P 500 Futures Rise On Cooling Inflation And Housing Jitters - Simply Wall St News

BioNTech SE
Webhose 2026 Jan 21, 23:44

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss

BioNTech SE
Webhose 2026 Jan 21, 21:42

BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why

BioNTech SE
Webhose 2026 Jan 19, 00:56

The Stock Market Is Closed on MLK Day, but Here's What Goldman Sachs Says to Buy When Trading Resumes | Markets Insider

BioNTech SE
Webhose 2026 Jan 16, 18:28

BioNTech (BNTX) Is Up 7.3% After Unveiling Ambitious Late-Stage Oncology Pipeline Expansion

BioNTech SE
Webhose 2026 Jan 15, 10:58

SG Americas Securities LLC Sells 69,726 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE
Webhose 2026 Jan 14, 11:33

A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update

BioNTech SE
Webhose 2026 Jan 14, 09:04

BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan

BioNTech SE
Webhose 2026 Jan 09, 13:51

Big Pharma turf war erupts: Bayer sues vaccine makers over alleged stolen mRNA technology - NaturalNews.com

BioNTech SE
Webhose 2026 Jan 09, 02:30

Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge

BioNTech SE
Webhose 2026 Jan 09, 00:00

Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms

BioNTech SE
Webhose 2026 Jan 08, 03:29

BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions

BioNTech SE
Webhose 2026 Jan 08, 00:43

Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach | Malay Mail

BioNTech SE
Webhose 2026 Jan 07, 13:03

Bayer sues Covid-jab makers, alleging patent violation

BioNTech SE
Webhose 2026 Jan 07, 10:24

Bayer's Monsanto Files Lawsuit Against Pfizer, BioNTech, and Moderna Over mRNA Patent Infringement, ETPharma

BioNTech SE
Webhose 2026 Jan 07, 00:34

BioNTech (NasdaqGS:BNTX) Valuation Check After Positive COVID 19 Vaccine Efficacy Data

BioNTech SE
Webhose 2026 Jan 03, 00:00

The Future of mRNA Is Being Built in APAC

BioNTech SE
Webhose 2026 Jan 01, 06:34

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2025 Dec 28, 11:39

BioNTech SE Sponsored ADR $BNTX Shares Sold by TB Alternative Assets Ltd.

BioNTech SE
Webhose 2025 Dec 28, 05:40

Swedbank AB Has $4.92 Million Stake in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech SE
Webhose 2025 Dec 26, 10:46

Vontobel Holding Ltd. Purchases 10,924 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

BioNTech SE

BioNTech News

Frances Wang 2026 Jan 21, 16:00

Gold hits a new record above $4800: What is gold price prediction for 2026?

Ghko B 2026 Jan 21, 16:00

Costco (COST) stock is rising: Is Costco a good stock to buy in 2026?

Frances Wang 2026 Jan 21, 16:00

Trending tech stocks analysis: Intel stock jumps 12%, NVDA shares up 3%

Ghko B 2026 Jan 21, 16:00

Nebius (NBIS) stock slips: What’s going on with Nebius Group (NASDAQ: NBIS)?

Frances Wang 2026 Jan 20, 16:00

Why Quantum Stocks Are Dropping: QBTS Stock, IONQ Stock, RGTI Stock

Ghko B 2026 Jan 20, 16:00

Forex CFD trading platform reviews 2026: markets.com, IG, Avatrade

Ghko B 2026 Jan 20, 16:00

ARK 21shares Bitcoin ETF (ARKB) analysis: Is ARKB a good investment?

Frances Wang 2026 Jan 20, 16:00

XLM price prediction in 2026: How much could Stellar (XLM) price be worth?

Ghko B 2026 Jan 19, 16:00

EV stocks today: TSLA is going down, Lucid (LCID) stock rises, RIVN drops

Ghko B 2026 Jan 19, 16:00

HBAR price prediction: Is Hedera (HBAR/USD) a good investment in 2026?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.8001

Spread (%)

0.6784 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

26488248320

Shares Outstanding

250930737

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.78

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Jan 21, 16:00

Crypto day trading: How to day trade crypto CFDs with markets.com?

Ghko B 2026 Jan 20, 16:00

Leverage trading: Difference between margin calls and forced liquidation

Ghko B 2026 Jan 19, 16:00

Futures CFDs trading: What is futures trading, how to trade futures?

Trustpilot